Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OBSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDZD11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDNF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TRMT10A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL1RAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAOA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LAMC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIDINS220 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIR3DL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPNPEP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PROSER2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC340107 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL13RA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AHI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on